Clinical trial
Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal…
NCT00387231 · Luzerner Kantonsspital, Other · Completed
Key facts
| NCT number | NCT00387231 |
|---|---|
| Title | Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction |
| Official title | Swiss Interventional Study on Silent Ischemia (SWISSI 2) |
| Lead sponsor | Luzerner Kantonsspital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Drug, Procedure |
| Interventions | Percutaneous coronary angioplasty/intervention (PCI), Anti-ischemic drug therapy |
| Start date | Jun 1, 1991 |
| Completion | May 1, 2006 |
| First posted | Oct 12, 2006 |
| Last update posted | Oct 12, 2006 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: